KindlyMD Shares Surge Amid New Stock Issuance Risks
By ATTN Desk · Editorial oversight: Sean Han
KINDLY MD INC (NASDAQ: KDLY)
Introduction
KINDLY MD INC, operating as KindlyMD™, is a healthcare and healthcare data company founded in 2019. It integrates traditional primary care and pain management with behavioral and alternative therapies, focusing on addressing both physical and mental health needs through evidence-based methods.
Corporate Structure and Team
- Founded: 2019
- Headquarters: Salt Lake City, Utah
- Employee Count: 51–200 (LinkedIn)
- Founder: Tim Pickett, MPAS-C
- Background in emergency medicine, trauma, and gastrointestinal surgery
- Focus on medical cannabis education and alternative pain therapies in Utah
Developments and Filings
May 20, 2025 – Form 8-K (Items 5.07, 7.01, 9.01)
KindlyMD filed a Current Report on Form 8-K, covering:
- Matters submitted to security holder votes
- Regulation FD disclosures
- Financial statements and exhibits
May 21, 2025 – Prospectus Supplement (Form 424B3)
A supplement to the May 6, 2025 prospectus was filed, detailing:
- 2,059,811 shares of common stock issuable upon warrant exercise
- 82,310 shares of common stock for resale by selling stockholders
- Common stock price as of May 20, 2025: $15.22 per share
- Tradeable warrant price: $8.00 per warrant
- Original warrants issued in the IPO on June 3, 2024
- Disclosure of risks related to dilution and use of proceeds
May 21, 2025 – Form 8-K (Items 7.01, 9.01)
Additional Regulation FD disclosures and updated financial exhibits were furnished on Form 8-K.
Financial and Strategic Analysis
Stock Performance (2025-05-22)
| Metric | Value |
|---|---|
| Stock Price | $29.6307 |
| Daily Change | +29.79% |
| Volume | 340,269 |
| Market Capitalization | $137.49 M |
| 52-Week Range | $0.65 – $31.45 |
Key Financial Metrics (TTM)
| Metric | Value |
|---|---|
| Revenue | $2.47 M |
| Net Income | −$4.37 M |
| EPS | −$0.73 |
| Profit Margin | −177.02% |
| Return on Assets | −154.31% |
| Return on Equity | −763.28% |
| Total Cash (MRQ) | $1.14 M |
| Debt/Equity (MRQ) | 43.58% |
| Price/Sales (TTM) | 55.65 |
| Price/Book (MRQ) | 89.92 |
Strategic Positioning
- Integrated Care Model
- Primary Care, Pain Management, Behavioral Health
- Medical Cannabis evaluation and education
- Weight loss programs with functional support
- Service Delivery
- Four clinic locations in Utah
- Telemedicine services available nationwide
- Investor Focus
- Holistic outpatient services
- The largest alternative pain treatment center in Utah
- Patient data analytics platform
Market Position and Industry Context
- Industry: Hospitals and Health Care
- Market Cap: Approximately $137.49 million
- Valuation Multiples: Elevated price/sales and price/book ratios typical of early-stage revenue profiles
- Profitability: Negative margins and cash flow reliance on equity and warrant exercises
- Sector Trends:
- Growth in integrated telehealth solutions
- Demand for non-opioid pain management alternatives
- Expansion of obesity and metabolic therapies
tl;dr
On May 22, 2025, KINDLY MD INC shares increased 29.79% to $29.63 (340K volume). On May 21, 2025, the company filed a Form 424B3 prospectus supplement for 2.06 million shares issuable on warrants and 82 thousand resale shares, noting dilution risk. Trailing twelve-month revenue was $2.47 million against a $4.37 million net loss. Operations are funded through equity raises and warrant exercises. KindlyMD’s integrated care offerings—encompassing primary care, behavioral health, pain management, and medical cannabis—are aligned with industry trends toward telehealth and alternative therapies. Future liquidity is likely dependent on warrant conversions and capital-raising activities.